Non-functioning Pituitary Adenoma Clinical Trial
Official title:
Effect of Dexmedetomidine on Intraoperative Neuroendocrine Stress Response and Early Postoperative Quality of Recovery in Non-functioning Pituitary Adenoma Patients Undergoing Endoscopic Transsphenoidal Tumor Surgery
In multiple previous studies that have explored the use of dexmedetomidine in transsphenoidal tumor resection surgery, dexmedetomidine showed many beneficial effects like reducing the requirement of analgesics and anesthetics, improving hemodynamic stability and decreasing the emergence time, extubation time and visual analog scale at emergence. Therefore, the investigators hypothesized that dexmedetomidine would decrease neuroendocrine stress response and improve the quality of postoperative recovery.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01283542 -
Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma.
|
Phase 2 | |
| Recruiting |
NCT06163261 -
Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma
|
N/A | |
| Active, not recruiting |
NCT04218721 -
Implementing eHealth Interventions Into Regular Clinical Practice
|
N/A |